On ECHEMI
Home > Drugs > Lacosamide Registered Holders
Lacosamide structure

Lacosamide structure

Lacosamide

White to Off-White SolidLacosamide (LCM), (SPM 927, (R)-2-acetamido-N-benzyl-3-methoxypropionamide, previously referred to as harkoseride or ADD 234037) is a member of a series of functionalized amino acids that were specifically synthesized as anticonvulsant or antiepileptic drug. It reduces the spread of seizure activity in the brain. Lacosamide appears to have a dual mode of action: selective enhancement of sodium channel inactivation and modulation of collapsin response mediator protein-2. 

Find 67 Related Holders

METROCHEM API PRIVATE LTD
United States United States

API Registration Country

API Active
CHROMO LABORATORIES INDIA PRIVATE LTD
United States United States

API Registration Country

API Active
LEE PHARMA LTD
United States United States

API Registration Country

API Active
INDOCO REMEDIES LTD
United States United States

API Registration Country

API Active
CURIA MISSOURI INC
United States United States

API Registration Country

API Active
JUBILANT BIOSYS LTD
United States United States

API Registration Country

API Active
ALIVUS LIFE SCIENCES LTD
United States United States

API Registration Country

API Active
ALEMBIC PHARMACEUTICALS LTD
United States United States

API Registration Country

API Active
APITORIA PHARMA PRIVATE LTD
United States United States

API Registration Country

API Active
ZYDUS LIFESCIENCES LTD
United States United States

API Registration Country

API Active
Recommended Suppliers of Lacosamide
View 97 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.